Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Relationship Between Novel Virological Indicators and Treatment With Different Nucleotide Analogues and the Prognosis of HBV-ACLF Patients

NCT07815418 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07815418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07815418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Relationship Between Novel Virological Indicators and Treatment With Different Nucleotide Analogues and the Prognosis of HBV-ACLF Patients
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Completed
Start date
February 1, 2022
Completion date
July 1, 2026
Enrollment
235 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute-on-chronic liver failure (aclf), hepatitisb, treatment